Proqr Therapeutics N V (PRQR)

07:35 AM

ProQR Therapeutics N.V (PRQR) Stock: A Year of Highs and Lows in the Market - investchronicle.com

07:35 AM

05:27 AM

Walleye Capital LLC Takes Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

05:27 AM

04:55 AM

ProQR Therapeutics (NASDAQ:PRQR) Sees Significant Decline in Short Interest - MarketBeat

04:55 AM

Apr 21, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Apr 21, 2025

Apr 20, 2025

Affinity Asset Advisors LLC Makes New Investment in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

Apr 20, 2025

Apr 20, 2025

575,000 Shares in ProQR Therapeutics (NASDAQ:PRQR) Bought by Altium Capital Management LLC - MarketBeat

Apr 20, 2025

Apr 16, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of “Buy” by Brokerages - Defense World

Apr 16, 2025

Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast - openPR.com

Apr 15, 2025

Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics - Barchart.com

Apr 15, 2025

Apr 14, 2025

ProQR (PRQR) Strengthens Leadership with New CFO and CMO Appointments | PRQR Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

ProQR Strengthens Leadership with Appointments of CFO and CMO to - GuruFocus

Apr 14, 2025

Apr 14, 2025

ProQR names new CFO and CMO to bolster RNA editing platform By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Not Doing Enough For Some Investors As Its Shares Slump 34% - simplywall.st

Apr 14, 2025

Apr 14, 2025

ProQR names new CFO and CMO to bolster RNA editing platform - Investing.com Canada

Apr 14, 2025

Apr 14, 2025

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth - GlobeNewswire

Apr 14, 2025

Apr 14, 2025

ProQR strengthens leadership team - The Pharma Letter

Apr 14, 2025

Apr 14, 2025

ProQR Therapeutics CFO Jurriaan Dekkers Steps Down, Dennis Hom To Succeed; Cristina Lopez Named CMO - Nasdaq

Apr 14, 2025

Apr 14, 2025

ProQR's Leadership Overhaul: New CFO Raised $4.5B, Led $57B in Deals - Stock Titan

Apr 14, 2025

Apr 14, 2025

American Century Companies Inc. Invests $237,000 in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Apr 14, 2025

Apr 12, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Acquired by Prudential Financial Inc. - Defense World

Apr 12, 2025

Apr 11, 2025

Raymond James Financial Inc. Acquires Shares of 97,928 ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Apr 11, 2025

Apr 01, 2025

Virtu Financial LLC Buys New Stake in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Apr 01, 2025

Mar 31, 2025

Chardan Capital Issues Optimistic Forecast for PRQR Earnings - MarketBeat

Mar 31, 2025

Mar 28, 2025

FY2025 EPS Estimate for ProQR Therapeutics Lifted by Analyst - Defense World

Mar 28, 2025

Mar 26, 2025

28,903 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by PNC Financial Services Group Inc. - Defense World

Mar 26, 2025

Mar 26, 2025

Analysts Set ProQR Therapeutics (NASDAQ:PRQR) Price Target at $9.50 - MarketBeat

Mar 26, 2025

Mar 25, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives $9.50 Average Target Price from Analysts - The AM Reporter

Mar 25, 2025

Mar 24, 2025

Privium Fund Management B.V. Sells 646,755 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

Mar 24, 2025

Mar 24, 2025

Platinum Investment Management Ltd. Makes New $4.08 Million Investment in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

Mar 24, 2025

Mar 22, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of “Buy” by Brokerages - Defense World

Mar 22, 2025

Mar 18, 2025

ProQR Therapeutics (NASDAQ:PRQR) Earns Buy Rating from Chardan Capital - MarketBeat

Mar 18, 2025

Mar 18, 2025

HC Wainwright Forecasts Strong Price Appreciation for ProQR Therapeutics (NASDAQ:PRQR) Stock - MarketBeat

Mar 18, 2025

Mar 17, 2025

H.C. Wainwright raises ProQR stock target to $12, maintains Buy By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

H.C. Wainwright raises ProQR stock target to $12, maintains Buy - Investing.com India

Mar 17, 2025

Mar 16, 2025

ProQR Therapeutics (NASDAQ:PRQR) Issues Quarterly Earnings Results - MarketBeat

Mar 16, 2025

Mar 16, 2025

Chardan Capital Reaffirms Buy Rating for ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Mar 16, 2025

Mar 14, 2025

Raymond James maintains Strong Buy on ProQR stock, $14 target By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Raymond James maintains Strong Buy on ProQR stock, $14 target - Investing.com India

Mar 14, 2025

Mar 14, 2025

ProQR Therapeutics NV earnings beat, revenue fell short of estimates - Investing.com

Mar 14, 2025

Mar 14, 2025

ProQR Therapeutics NV earnings beat, revenue fell short of estimates By Investing.com - Investing.com South Africa

Mar 14, 2025